Wageningen University, Division of Human Nutrition
Wageningen, Gelderland, Netherlands
NCT Number: NCT01215370
The main objective is to investigate the postprandial effect of arginine-rich protein (i.e. pea-protein) on metabolic control, inflammation and endothelial function after a high-fat meal in subjects with characteristics of the metabolic syndrome.
Looking for future studies?
Notify Me45 year–70 year
Male
Interventional
Not applicable
Wageningen, Gelderland, Netherlands
Arginine is potential interesting considering the metabolic syndrome. Studies so far indicated both long-term effects, as well as acute - postprandial - actions; especially when metabolism is already challenged, e.g. in diabetic patients or after a high-fat meal. If arginine-rich proteins are equally effective is not known. Therefore we are interested in the effect of (arginine rich) protein on postprandial (dys)metabolism, inflammation and endothelial function, within 6 hours after a meal.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
plus any one of the following four factors:
Additional inclusion criteria:
Exclusion criteria
Shake containing 95 gram of fat, additive 30 gram pea protein
Other names: Experimental
Shake containing 95 gram of fat, additive 30 gram gluten protein hydrolysate
Other names: Experimental
Shake containing 95 gram of fat, no protein additive
Other names: Control
Shake containing 95 gram of fat, additive 30 gram gluten protein.
Other names: Experimental
Shake containing 95 gram of fat, additive 30 gram gluten gluten hydrolysate
Other names: Experimental
Time frame: up to 6 hours
Metabolic: Plasma glucose, insulin and triglyceride levels (T= 0,1,2,3,4,5 and 6 hrs)
Inflammatory: C-reactive protein (CRP), Plasminogen activator inhibitor-1 (PAI-1), Tumor necrosis factor-alpha (TNF-a), Interleukin-6 (IL-6), Inter-Cellular Adhesion Molecule-1 (ICAM-1) and Monocyte chemotactic protein-1 (MCP-1) (T=0, 2, 4 and 6 hrs).
Endothelial function: Macro vascular regional arterial stiffness by Pulse Wave Analysis (PWA) (T=0, 3 and 6 hrs).
Time frame: up to 6 hours
Satiety: Glucagon-like peptide-1 (GLP-1) (T=0,2,4 and 6 hrs).
Oxidative stress: Peripheral blood mononuclear cells (PBMC) (T=0,3 and 6 hrs).
Wageningen University
Other
Effect of Arginine-rich Dietary Protein on Postprandial Metabolism, Inflammation and Endothelial Function
Acronym: PEA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04057339
Behavior, Fasting
La Jolla, California, United States
View Trial DetailsNCT07702669
Glucose Metabolism Disorders, Hyperinsulinism
Harbin, Heilongjiang, China
View Trial DetailsNCT06461273
Behavior, Body Weight
Newark, New Jersey, United States
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial Details